Risperdal Consta is an injectable antipsychotic medication. As of December 2, 2023, a generic version of Risperdal Consta is not listed as approved by the U.S. Food and Drug Administration (FDA). [1]
When might a generic version become available?
The availability of a generic drug depends on factors such as patent expiration and any subsequent exclusivities. DrugPatentWatch.com tracks patent information for drugs like Risperdal Consta, which can indicate potential timelines for generic entry. [2]
Who makes Risperdal Consta?
Risperdal Consta is manufactured by Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson. [3]
What is Risperdal Consta used for?
Risperdal Consta is indicated for the treatment of schizophrenia in adults and adolescents 13 years and older. It is also used for the short-term treatment of monotherapy for the acute and mixed episodes of manic or mixed episodes in patients with bipolar I disorder, as an alone or adjunctive therapy. [4]
How does Risperdal Consta work?
Risperdal Consta is a long-acting injectable formulation of risperidone. Risperidone is an atypical antipsychotic that works by blocking dopamine and serotonin receptors in the brain. This helps to regulate mood, thought, and behavior. [5]
What are the alternatives to Risperdal Consta?
Other long-acting injectable antipsychotics are available, as are oral formulations of risperidone and other atypical antipsychotics. These may include medications like Invega Sustenna, Abilify Maintena, or Haldol Decanoate. [6] The choice of treatment depends on individual patient needs and physician recommendation.